For example, in renal cell carcinoma, sunitinib has been shown to suppress the activation of STAT3 [23], a nuclear transcription factor considered critical for promoting proliferation, resistance to apoptosis, and tumorigenesis [24]. The gene discussed is STAT3; the disease is hereditary clear cell renal cell carcinoma.